Table 2.
No. of Study Participants
|
|||||
---|---|---|---|---|---|
Characteristics | Total (N=91) | Principal Investigator (n=34) | Research Staff (n=33) | Referring Clinician (n=16) | Cancer Ctr. Leadership (n=8) |
Mean Age (years) | 51 | 46 | 52 | 48 | 60 |
Gender | |||||
Men | 43 | 21 | 3 | 12 | 7 |
Women | 48 | 13 | 30 | 4 | 1 |
Race | |||||
Caucasian | 67 | 24 | 26 | 10 | 7 |
African American | 11 | 3 | 5 | 3 | 0 |
Asian | 13 | 7 | 2 | 3 | 1 |
Ethnicity | |||||
Non-Hispanic | 76 | 29 | 30 | 11 | 6 |
Hispanic | 15 | 5 | 3 | 5 | 2 |
Mean number of years cancer trial experience | 12 | 11 | 10 | 13 | 24 |
Type of trial | |||||
Therapeutic | 27 | 4 | 19 | 2 | 2 |
Non-therapeutic | 6 | 5 | 1 | 0 | 0 |
Therapeutic and non-therapeutic | 56 | 24 | 12 | 14 | 6 |
Not indicated | 2 | 1 | 1 | 0 | 0 |